Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/eurheartj/sux002 http://scihub22266oqcxt.onion/10.1093/eurheartj/sux002 C5932558!5932558!29249907     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+Heart+J+Suppl 2017 ; 19 (Suppl C): C22-8 Nephropedia Template TP {{tp|p=29249907|t=2017. Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan |pdf=|usr=}}{{29249907}} gab.com Text Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan JO: Eur Heart J Suppl http://www.kidney.de/pget.php?&tw=1&pmid=29249907 #FOAvip Pathological interplay between the heart and kidneys?also known as cardio-renal syndrome (CRS)?is frequently encountered in heart failure and is linked to worse prognosis and quality of life. Drug therapies for this complex situation may include nitroprusside or the recombinant B-type natriuretic peptide nesiritide for patients with acute CRS with normal or high blood pressure, and inotropes or inodilators for patients with acute CRS with low blood pressure. Clinical data for a renal-protective action of levosimendan are suggestive, and meta-analysis data obtained in a range of low-output states are consistent with a levosimendan-induced benefit. Evidence of favourable organ-specific effects of levosimendan, including pre-glomerular vasodilation and increased renal artery diameter and renal blood flow, were collected both in preclinical and clinical studies. Larger randomized controlled trials are however needed to confirm the renal effects of levosimendan in various clinical settings. Twit Text FOAVip Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan ????Eur Heart J Suppl http://www.kidney.de/pget.php?&tw=1&pmid=29249907 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29249907 #FOAvip English Wikipedia <ref>{{Cite pmid|29249907}}</ref> Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan #MMPMID29249907 Fedele F; Karason K; Matskeplishvili S Eur Heart J Suppl 2017[Mar]; 19 (Suppl C): C22-8 PMID29249907show ga Pathological interplay between the heart and kidneys?also known as cardio-renal syndrome (CRS)?is frequently encountered in heart failure and is linked to worse prognosis and quality of life. Drug therapies for this complex situation may include nitroprusside or the recombinant B-type natriuretic peptide nesiritide for patients with acute CRS with normal or high blood pressure, and inotropes or inodilators for patients with acute CRS with low blood pressure. Clinical data for a renal-protective action of levosimendan are suggestive, and meta-analysis data obtained in a range of low-output states are consistent with a levosimendan-induced benefit. Evidence of favourable organ-specific effects of levosimendan, including pre-glomerular vasodilation and increased renal artery diameter and renal blood flow, were collected both in preclinical and clinical studies. Larger randomized controlled trials are however needed to confirm the renal effects of levosimendan in various clinical settings. äPharmacological approaches to cardio-renal syndrome: a role for the in(epmc).pdf DeepDyve Pubget Overpricing